Curcumin references
1. Chan MM, Fong D, Soprano KJ, Holmes WF, Heverling H. Inhibition of growth
and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic
chemopreventive agents. J Cell Physiol. 2003 Jan;194(1):63-70.
2. Navis I, Sriganth P, Premalatha B. Dietary Curcumin with cisplatin administration
modulates tumor marker indices in experimental fibrosarcoma. Pharmacological
Research. 1999 Mar;39(3):175-79.
3. Ichiki K, Mitani N, Doki Y, Hara H, Misaki T, Saiki I. Regulation of activator
protein-1 activity in the mediastinal lymph node metastasis of lung cancer.
Clin Exp Metastasis.2000;18(7):539-45.
4. Bharti AC, Donato N, Singh S, Aggarwal BB. Curcumin (diferuloylmethane)
downregulatesthe constitutive activation of nuclear factor-kappa B and IkappaBalpha
kinase in human multiple myeloma cells, leading to suppression of proliferation
and induction
of apoptosis. Blood. 2003 Feb;101(3):1053-62.
5. Lin JK, Chen YC, Huang YT, Lin-Shiau SY. Suppression of protein kinase C
and nuclear oncogene expression as possible molecular mechanisms of cancer chemoprevention
by apigenin and Curcumin. J Cell Biochem Suppl. 1997;28-29:39-48.
6. Cheng AL, Hsu Ch, Lin JK, et al. Phase I clinical trial of Curcumin, a chemopreventive
agent, in patients with high-risk or pre-malignant lesions. Anticancer Res.
Jul-Aug2001;21(4B):2895-2900.
7. Miyoshi N, Nakamura Y, Ueda Y, et al. Dietary ginger constituents, galanals
A and B, arepotent apoptosis inducers in Human T lymphoma Jurkat cells. Cancer
Lett. 2003 Sep25;199(2):113-9.
8. Chan WH, Wu CC, Yu JS. Curcumin inhibits UV-induced oxidative stress and
apoptotic biochemical changes in human epidermoid carcinoma A431 cells. J Cell
Biochem. Oct 2003;90(2):327-38.
9. Menon LG, Kuttan R, Kuttan G. Antimeta-static activity of Curcumin and catechin.Cancer
Lett 1999 Jul 1;141(1-2):159-65.
10. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of Curcumin: preclinical
and clinical studies. Anticancer Res. Jan-Feb 2003;23(1A):363-98.
11. Ikezaki S, Nishikawa A, Furukawa F, et al. Chemopreventive effects of Curcumin
on glandular stomach carcinogenesis induced by N-methyl-N-nitro-N-nitrosoguanidine
and sodium chloride in rats. Anticancer Res. 2001 Sep-Oct;21(5):3407-11.
12. Dorai T, Cao YC, Dorai B, Buttyan R, Katz AE. Therapeutic potential of
Curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces
apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo.
Prostate. 2001 Jun 1;47(4):293-303.
13. Nakamura K, Yasunaga Y, Segawa T, et al. Curcumin down-regulates AR gene
expression and activation in prostate cancer cell lines. Int J Oncol. 2002 Oct;21(4):825-30.
14. Hour TC, Chen J, Huang CY, Guan JY, Lu SH, Pu YS. Curcumin enhances cytotoxicity
of chemotherapeutic agents in prostate cancer cells by inducing p21(WAF1/CIP1)
and C/EBPbeta expressions and suppressing NF-kappaB activation. Prostate. 2002
May
15;51(3):211-8.
15. Gururaj AE, Belakavadi M, Venkatesh DA, Marme D, Salimath BP. Molecular
mechanisms of anti-angiogenic effect of Curcumin. Biochem Biophys Res Commun.2002
Oct 4;297(4):934-42.
16. Cheng PY, Wang M, Morgan ET. Rapid transcriptional suppression of rat Cyto-chrome
P450 genes by endotoxin treatment and its inhibition by Curcumin. J Pharmacol
Exp Ther. 2003 Oct 13 [Epub ahead of print].
17. Ray SN, Chattopadhyay N, Mitra A, Siddiqi M, Chatterjee A. Curcumin exhibits
antimetastatic properties by modulating integrin receptors, collagenase activity,
and expression of Nm23 and E-cadherin. J Environ Pathol Toxicol Oncol. 2003;22(1):49-58.
18. Reddy BS, Rao CV. Novel approaches for colon cancer prevention by cyclooxygenase-2
inhibitors. J Environ Pathol Toxicol Oncol 2002;21(2):155-64.
19. Somasundaram S, Edmund NA, Moore DT, Small GW, Shi YY, Orlowski RZ. Dietary
Curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer.
Cancer Res. 2002 Jul 1;62(13):3868-75.
20. Imaida K, Tamano S, Kato K, et al. Lack of chemopreventive effects of lycopene
and Curcumin on experimental rat prostate car cinogenesis. Carcinogenesis. 2001
Mar;22(3):467-72.
21. Satoskar RR, Shah SJ, Shenoy SG. Evaluation of anti-inflammatory property
of curcumin in patients with postoperative inflammation. Int J Clin Pharmacol
Ther Toxicol 1986 Dec;24(12):651-4.
22. Kulkarni RR, Patki PS, Jog VP, Gandage SG, Patwardhan B. Treatment of osteoarthritis
with a herbomineral formulation: a double-blind, placebo-controlled, cross-over
study.J Ethnopharmacol. 1991 May-Jun;33(1-2):91-5.
23. Arora RB, Basu N, Kapoor V, Jain AP. Anti-inflammatory studies on Curcuma
longa (turmeric). Ind J Med Res 1971 Aug;59(8):1289-95.
24. Deodhar SD, Sethi R, Srimal RC. Preliminary studies on antirheumatic activity
ofCurcumin (diferuloyl methane). Ind J Med Res. 1980 Apr;71:632-4.
25. Chan MM, Ho CT, Huang HI. Effects of three dietary phytochemicals from
tea, rosemary and turmeric on inflammation-induced nitrate production. Cancer
Lett. 1995 Sep 4;96(1):23-9.
26. Ramsewak RS, DeWitt DL, Nair MG. Cytotoxicity, antioxidant and anti-inflammatory
activities of curcumins I-III from Curcumalonga. Phytomedicine. Jul 2000;7(4):303-8.
27. Mesa MD, Aguilera CM, Ramirez-Tortosa CL, et al. Oral administration of
a turmeric extract inhibits erythrocyte and liver microsome membrane oxidation
in rabbits fed with an atherogenic diet. Nutrition. Sep 2003;19(9):800-04.
28. Quiles JL, Aguilera C, Mesa MD, Ramirez- Tortosa MC, Baro L, Gil A. An
ethanolic-aqueous extract of Curcuma longa decreases the susceptibility of liver
microsomes and mitochondria to lipid peroxidation in atherosclerotic rabbits.
Biofactors. 1998;8(1- 2):51-7.
29. Dikshit M, Rastogi L, Shukla R, Srimal RC. Prevention of ischaemia-induced
biochemical changes by Curcumin & quinidine in the cat heart. Indian J Med
Res. Jan 1995;101:31-5.
30. Ramirez-Tortosa MC, Mesa MD, Aguilera MC, et al. Oral administration of
a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects
in rabbits with experimental atherosclerosis. Atherosclerosis. Dec 1999;147(2):371-8.
31. Quiles JL, Mesa MD, Ramirez-Tortosa CL, et al. Curcuma longa extract supplementation
reduces oxidative stress and attenuates aortic fatty acid streak development
in rabbits.Arterioscler Thromb Vasc Biol. Jul 2002 Jul 1;22(7):1225-31.
32. Suryanarayana P, Krishnaswamy K, Reddy GB. Effects of Curcumin on galactose-inducedcataractogenesis
in rats. Mol Vis. 2003 Jun 9;9:223-30.
33. Galvano F, Piva A, Ritieni A, Galvano G. Dietary strategies to counteract
the effects of mycotoxins: a review. J Food Prot. Jan 2001;64(1)120-31.
34. Koide T, Nose M, Ogihara Y, Yabu Y, Ohta N. Leishmanicidal effects of Curcumin
in vitro.Biol Pharm Bull. 2002 Jan;25(1):131-3.
35. Saleheen D, Ali SA, Ashfaq K, Siddiqui AA, Agha A, Yasinzai MM. Latent
activity of cur-cumin against leishmaniasis in vitro. Biol Pharm Bull. 2002
Mar;25(3):386-9.
36. Shishu, Singla AK, Kaur IP. Inhibitory effect of Curcumin and its natural
analogues o geneto toxicity of heterocyclic amines from cooked food. Indian
J Exp Biol. Dec 2002 Dec;40(12):1365-72.
37. Phan TT, See P, Lee ST, Chan SY. Protective effects of Curcumin against
oxidative damage on skin cells in vitro: its implication for wound healing.
J Trauma. 2001 Nov;51(5):927-31.
38. Natarajan C, Bright JJ. Curcumin inhibits experimental allergic encephalomyelitis
byblocking signalling through janus kinase- STAT pathway in T lymphocytes IL-12.
JImmunol. 2002;168(12):6506-13.
39. Arun N, Nalini N. Efficacy of turmeric on blood sugar and polyol pathway
in diabetic albino rats. Plant Foods Hum Nutr. 2002;57(1):41-52.
40. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. The curry spice
Curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic
mouse. J Neurosci. 2001 Nov 1;21(21):8370-7. 41. Kim DS, Park SY, Kim JK. Curcuminoids
from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma
and normal human umbilical vein endothelial cells from beta(1-42) insult. Neurosci
Lett. Apr 2001;303(1):57-61.
42. Lal B, Kapoor AK, Asthana OP, et al. Efficacy of Curcumin in the management
of chronic anterior uveitis. Phytotherapy Res 1999;13:318-22.
43. White EL, Ross LJ, Schmid SM, Kelloff GJ, Stelle VE, Hill DL. Screening
of potential cancer preventing chemicals for induction of glutathionine in rat
liver cells. Oncol Rep. 1998 Mar-Apr;5(2):507-12.
44. Inano H, Makota O. Prevention of radiation-induced mammary tumors. Int
J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):212-23.
45. Inano H, Onoda M. Radioprotective action of Curcumin extracted from Curcuma
longa LINN: inhibitory effect on formation of urinary 8-hydroxy-2′-deoxyguanosine,
tumorogenesis, but not mortality, induced by gamma-ray irradiation. Int J Radiat
Oncol BiolPhys. 2002 Jul 1;53(3):735-43.
46. Ghoneim AI, Abdel-Naim AB, Khalifa AE, El-Denshary ES. Protective effects
of curcumin against ischaemis-reperfusion insult in rat forebrain. Pharmacol
Res. Sep 2002;46(3):273-9.
47. Sreejayan, Rao MN. Curcuminoids as potent inhibitors of lipid peroxidation.
J IndianPhysiol Pharmacol. Dec 1994;46(12):1013-6.
48. Soni KB, Kuttan R. Effects of Curcumin administration on serum peroxides
and cholesterol levels in human volunteers. Indian J Physiol Pharmacol. Oct
1992;36(4):273-5.
49. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence
of piperine onthe pharmacokinetics of Curcumin in animals and human volunteers.
Planta Med. 1998 May;64(4):353-6.
50. Jayaraman KS. US patent office withdraws patent on Indian herb. Nature.
1997 Sep 4;389(6646):6.